These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25987021)

  • 21. Dissection of miRNA-miRNA interaction in esophageal squamous cell carcinoma.
    Wu B; Li C; Zhang P; Yao Q; Wu J; Han J; Liao L; Xu Y; Lin R; Xiao D; Xu L; Li E; Li X
    PLoS One; 2013; 8(9):e73191. PubMed ID: 24039884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
    Ishibashi O; Akagi I; Ogawa Y; Inui T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
    Suzuki S; Yokobori T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Oncol Rep; 2012 Aug; 28(2):465-72. PubMed ID: 22641236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
    Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network Analyses of Gene Expression following Fascin Knockdown in Esophageal Squamous Cell Carcinoma Cells.
    Du ZP; Wu BL; Xie JJ; Lin XH; Qiu XY; Zhan XF; Wang SH; Shen JH; Li EM; Xu LY
    Asian Pac J Cancer Prev; 2015; 16(13):5445-51. PubMed ID: 26225692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The global expression profiling in esophageal squamous cell carcinoma.
    Dai F; Mei L; Meng S; Ma Z; Guo W; Zhou J; Zhang J
    Genomics; 2017 Jul; 109(3-4):241-250. PubMed ID: 28442363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
    Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
    Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
    Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network.
    Shen Y; Tantai J; Zhao H
    Eur J Med Res; 2014 Oct; 19(1):52. PubMed ID: 25358439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
    Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
    Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA and target mRNA selection through invasion and cytotoxicity cell modeling and bioinformatics approaches in esophageal squamous cell carcinoma.
    Lu M; Song Y; Fu W; Liu Y; Huai S; Cui X; Pang L; Yang L; Wei Y
    Oncol Rep; 2017 Aug; 38(2):1181-1189. PubMed ID: 28677800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
    Mei LL; Qiu YT; Zhang B; Shi ZZ
    Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression profiling of metastasis-related microRNAs in early esophageal squamous cell carcinoma].
    Lu J; Xue L; Jin M; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):313-7. PubMed ID: 25030863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
    Sun YL; Liu F; Liu F; Zhao XH
    World J Gastroenterol; 2016 Aug; 22(32):7322-31. PubMed ID: 27621578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.